Gilead Sciences (GILD) stock analysis
A free, instant KC Score and technical read on Gilead Sciences, from the last 12 months of price data.
Gilead Sciences
Strong, established uptrend with positive momentum.
3-month +19.5%, 6-month +12.4%.
Price is above its 50-day and above its 200-day average; 50DMA above 200DMA.
Trading 4% below its 52-week high — 87% of the way up its yearly range.
Annualised volatility ~26% — moderately choppy.
The KC Score is a transparent 0–100 read of Gilead Sciences's recent price behaviour, built from ~12 months of daily closing prices. Momentum weighs 3- and 6-month returns; Trend checks price against its 50- and 200-day moving averages; Range strength measures where it sits in its 52-week range; Stability reflects volatility. It is a descriptive technical summary — not a forecast, price target, or recommendation to buy or sell. Markets change daily; re-check before acting and do your own research.
What the KC Score says about Gilead Sciences
Gilead Sciences (GILD) currently carries a KC Score of 88 out of 100 — a grade of A. In plain terms: strong, established uptrend with positive momentum. The score is a transparent, rules-based read of roughly the last twelve months of Gilead Sciences's daily closing prices. It describes momentum, trend, range position and stability — it is not a buy or sell recommendation, and it knows nothing about Gilead Sciences's valuation, earnings or news. At the last hourly update the stock traded near USD150.93, up 0.8% on the session, sitting 87% of the way up its 52-week range and about 4.0% below its 52-week high.
Momentum scores 78 out of 100. Over the past three months Gilead Sciences has moved 19.5%, and 12.4% over six months — a broadly positive run that lifts the momentum reading. On trend (100/100), the price is above its 50-day moving average and above its 200-day average. Both averages sitting below the price is the classic shape of an established uptrend.
Range position scores 87/100: at 87% of its 52-week band, Gilead Sciences is trading toward the top of where it has been over the last year. Stability scores 84/100, off annualised volatility of about 26% — relatively low for a single stock. Lower volatility means steadier day-to-day movement, though it is never a guarantee against a large fall.
For a long-term investor, one stock's score matters far less than the system around it: keeping costs low, staying diversified, and giving compounding time to work. Treat GILD's reading as a single input, not a verdict, and compare it against other Healthcare names rather than in isolation. The math always wins — a low-cost, broadly diversified portfolio held for years reliably beats reacting to any one score, including this one.
Commission-free ISAs & general accounts. Not a recommendation — compare fees and features yourself.
Some links are affiliate links — we may earn a commission at no extra cost to you. This never affects our analysis.
Gilead Sciences (GILD) — frequently asked
Is the KC Score a buy or sell signal?
No. It is an educational, rules-based description of recent price behaviour — momentum, trend, range and stability. It carries no view on valuation, fundamentals or news, and nothing here is financial advice. Your capital is at risk.
What data is the score based on?
Roughly the last twelve months of daily closing prices from public market data. The same transparent formula is applied to every stock, so scores are comparable across the site.
How often does it update?
Prices and the score refresh hourly, automatically. You may see a slightly different reading later in the day as new prices come in.
Hold GILD? See what your whole portfolio says about you.
AlphaScore reads your real trade history and names your investor type — your edge, your blind spots, your next moves. Your statement never leaves your device. Free.